Verastem, Inc. to Present at the 23rd Annual Oppenheimer Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the management team will be presenting at the 23rd Annual Oppenheimer Healthcare Conference being held December 12-13, 2012 at the Waldorf-Astoria in New York, NY. The presentation details are as follows: A panel discussion titled “Toward Personalized Medicine” on Thursday, December 13, 2012 at 8:35 am ET in the Jade room.